General strategy for the preparation of membrane permeable fluorogenic peptide ester conjugates for in vivo studies of ester prodrug stability

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 3, 2004, Pages 545-552

  Li, Xiaoxu ^a   Taylor, John Stephen ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

Arg9 peptide; Fluorescein; Fluorogenic ester; Prodrug

Indexed keywords

AMINO ACID; ARGININE; CYSTEINE; ESTER; FLUORESCEIN DERIVATIVE; PRODRUG; TYROSINE;

ARTICLE; CELL MEMBRANE; DRUG STABILITY; MEMBRANE PERMEABILITY;

EID: 0347761410     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.11.016     Document Type: Article

References (24)

1. Ma Z., Taylor J.-S. Proc. Natl. Acad. Sci. U.S.A. 97:2000;11159.
2. Ma Z., Taylor J.S. Bioorg. Med. Chem. 9:2001;2501.
3. Ma Z., Taylor J.S. Bioconjug. Chem. 14:2003;679.
4. Stoeckel K., Hofheinz W., Laneury J.P., Duchene P., Shedlofsky S., Blouin R.A. Antimicrob. Agents Chemother. 42:1998;2602.
5. Oliyai R., Shaw J.P., Sueoka-Lennen C.M., Cundy K.C., Arimilli M.N., Jones R.J., Lee W.A. Pharm. Res. 16:1999;1687.
6. Yang C., Gao H., Mitra A.K. J. Pharm. Sci. 90:2001;617.
7. Rukavishnikov A.V., Smith M.P., Birrell G.B., Keana J.F., Griffith O.H. Tetrahedron Lett. 39:1998;6637.
8. Zaikova T.O., Rukavishnikov A.V., Birrell G.B., Griffith O.H., Keana J.F.W. Bioconjug. Chem. 12:2001;307.
9. Kasai K., Okada K., Yamaji N. Chem. Pharm. Bull. 41:1993;1513.
10. Rotman B., Papermaster B.W. Proc. Natl. Acad. Sci. U.S.A. 55:1966;134.
11. Aeschbacher M., Reinhardt C.A., Zbinden G. Cell Biol. Toxicol. 2:1986;247.
12. Prosperi E., Croce A.C., Bottiroli G., Supino R. Cytometry. 7:1986;70.
13. Prosperi E. Histochem. J. 22:1990;227.
14. Breeuwer P., Drocourt J.L., Bunschoten N., Zwietering M.H., Rombouts F.M., Abee T. Appl. Environ. Microbiol. 61:1995;1614.
15. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., Steinman L., Rothbard J.B. Proc. Natl. Acad. Sci. U.S.A. 2000;97.
16. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., Sugiura Y. J. Biol. Chem. 276:2001;5836.
17. Suzuki T., Futaki S., Niwa M., Tanaka S., Ueda K., Sugiura Y. J. Biol. Chem. 277:2002;2437.
18. Rothbard J.B., Kreider E., VanDeusen C.L., Wright L., Wylie B.L., Wender P.A. J. Med. Chem. 45:2002;3612.
19. Gammon S.T., Villalobos V.M., Prior J.L., Sharma V., Piwnica-Worms D. Bioconjug. Chem. 14:2003;368.
20. Rothbard J.B., Garlington S., Lin Q., Kirschberg T., Kreider E., McGrane P.L., Wender P.A., Khavari P.A. Nat. Med. 6:2000;1253.
21. Chen L., Wright L.R., Chen C.H., Oliver S.F., Wender P.A., Mochly-Rosen D. Chem. Biol. 8:2001;1123.
22. Jin L.H., Bahn J.H., Eum W.S., Kwon H.Y., Jang S.H., Han K.H., Kang T.C., Won M.H., Kang J.H., Cho S.W., Park J., Choi S.Y. Free Radic. Biol. Med. 31:2001;1509.
23. Corey E.J., Gras J.L., Ulrich P. Tetrahedron Lett. 1976;809.
24. Frazier, K. A. in U.S. Patent 4980482 (The Dow Chemical Company, US), 1990 pp 4.